Ranjitkar Manandhar, N.; Kayastha, G. K.; Acharya, P. K. Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study. JPAHS 2018, 5, 47-56.